tirzepatide judge ruling UPDATE [March 7, 2025]: OFA takes case to appeals court as legal battle evolves Eli Lilly’s Tirzepatide Lawsuit Loss!

Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery

More about Mounjaro (tirzepatide) Check interactions Compare alternatives Pricing & coupons Reviews (2,056) Drug images Latest FDA alerts (2) Side effects Dosage information Patient tips During pregnancy Support group FDA approval history Drug class: GLP-1 Drugs Breastfeeding En espaol Patient resources Professional resources Other brands Related treatment guides Copyright 2022, 2026, Eli Lilly and Company

Constipation is a known, manageable side effect and does not predict poor results or intolerance when addressed with proper medical guidance

Another study showed that after 26 weeks of treatment with a different GLP-1 receptor agonist (liraglutide), people had improvements in their mental health and energy levels, compared to people who received a placebo.

Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, doubleblind, parallelarm, phase 1 clinical trial

Patients should increase fiber gradually to avoid exacerbating gastrointestinal symptoms during medication adjustment